Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Latest in Hematology-Oncology

AstraZeneca and Eli Lilly have announced plans to combine two cancer drugs–one experimental and one previously approved–in clinical trials to test the efficacy against solid tumors, according to Reuters. The new drug is designed as  immune...
Researchers are arguing against the increasingly prominent trend of offering genetic testing to determine a patient’s risk for breast cancer until the efficacy and accuracy of the tests can be better determined, according to a report from Reuters....
CBS News reports a study published in the Journal of the National Cancer Institute which suggests women who breastfeed their infants and later develop breast cancer are less likely to have a recurrence of the cancer or to die from it than women who do...